MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Cincinnati Enquirer: UC students win Flying Pig races
May 6, 2024
University of Cincinnati students won championships in the 2024 Flying Pig Marathon, including the women's marathon and men's and women's half marathons, the Cincinnati Enquirer reported.
Washington Post: The hour after leaving day care is a...
May 6, 2024
The Washington Post highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researchers that found kids eat fewer healthy foods and take in 22 percent of their day’s added sugar intake in the single hour after they’re picked up from child care.
Local news highlights UC's artificial intelligence programs
May 6, 2024
UC College of Engineering and Applied Science Professor Ali Minai tells WLWT and WVXU that AI is becoming a popular subject among new students.